3-methylglutaconic aciduria type 4

3-methylglutaconic aciduria type 4 (also called MGA type 4 or non-specific 3-methylglutaconic aciduria) is a rare inherited metabolic disorder. In this condition, the body builds up too much of a chemical called 3-methylglutaconic acid in the blood and urine. Unlike some other types of 3-methylglutaconic aciduria, type 4 does not have a single known cause — it is considered a 'catch-all' category for cases where the exact genetic or biochemical defect has not been clearly identified. This makes it one of the least well-defined subtypes. The condition mainly affects the brain, muscles, and heart. Children with MGA type 4 often show signs early in life, including developmental delays, muscle weakness, and problems with movement and coordination. Some children also develop heart problems. Symptoms can vary widely from person to person, ranging from mild to very severe. Because this is a broad category, some patients may later be reclassified when a more specific genetic cause is found. There is currently no cure for MGA type 4. Treatment focuses on managing symptoms, supporting development through therapies, and monitoring for complications like heart disease. A team of specialists is usually needed to provide the best care. Early diagnosis and supportive care can help improve quality of life.

Bring these to your next appointment

• Q1.Has my child been tested to rule out all other known subtypes of 3-methylglutaconic aciduria?,Should we pursue whole exome or whole genome sequencing to look for a specific genetic cause?,Does my child need a heart ultrasound, and how often should heart function be monitored?,What therapies (physical, occupational, speech) would benefit my child most right now?,Are there any clinical trials or research studies we could participate in?,What signs should prompt me to seek emergency care?,Are there any dietary changes or supplements that might help manage symptoms?

Common questions about 3-methylglutaconic aciduria type 4